Med Life (FRA:O0C) Moat Score: 0/10 (As of Jul. 11, 2026)


FRA:O0C Med Life SA FRA:O0C
60 GF Score
Price €2.28
GF Value €1.50
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Med Life Moat Score?

Med Life has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Med Life has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Med Life might have No Moat - No discernible moat.

Med Life  (FRA:O0C) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Med Life Moat Score Related Terms

FRA:O0C
60GF Score
Med Life SA FRA:O0C
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Med Life (FRA:O0C) Overvalued in 2026?

Based on GuruFocus' analysis, Med Life stock appears to be overvalued. The current stock price of €2.28 is trading 51.7% above its estimated GF Value™ of €1.50. GuruFocus considers Med Life to be Significantly Overvalued.

Key valuation signals for FRA:O0C:

  • Moat Score: 0
  • GF Value™: €1.50 vs. price of €2.28 (51.7% above fair value)
  • GF Score™: 60/100 with 7 warning signs

No single metric tells the full story. See the FRA:O0C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Med Life Business Description

Other Exchanges M:Romania0RO5:UK
Address Calea Grivitei, No. 365, District 1, Bucharest, ROU
Med Life SA is a healthcare provider in Romania. The Company's activity resides in the performance of healthcare services activities through medical centres with national coverage. It is engaged in the provision of rendering of medical services, rental of medical facilities and acquisition of materials and commodities. The company provides medical service through Hyper clinics in Arad, Bucharest, Braila, Brasov, Cluj, Constanta, Craiova, Galati, Iasi, Oradea, Ploiesti, Sibiu and Timisoara; Clinics, hospitals located in Bucharest, Arad, Sibiu, Brasov, Cluj and Ploiesti, Laboratories, Pharmacies and Dental Clinics.
60GF Score

Get the complete analysis for FRA:O0C

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.28
Price
€1.50
GF Value